Carbamazepine in the treatment of bulimia

Of six bulimic outpatients who completed a double-blind crossover trial with carbamazepine, one patient, who had a history suggestive of bipolar disorder, responded dramatically with cessation of binge eating. This supports a possible link in some patients between bulimia and affective illness.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of psychiatry 1983-09, Vol.140 (9), p.1225-1226
Hauptverfasser: KAPLAN, A. S, GARFINKEL, P. E, DARBY, P. L, GARNER, D. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1226
container_issue 9
container_start_page 1225
container_title The American journal of psychiatry
container_volume 140
creator KAPLAN, A. S
GARFINKEL, P. E
DARBY, P. L
GARNER, D. M
description Of six bulimic outpatients who completed a double-blind crossover trial with carbamazepine, one patient, who had a history suggestive of bipolar disorder, responded dramatically with cessation of binge eating. This supports a possible link in some patients between bulimia and affective illness.
doi_str_mv 10.1176/ajp.140.9.1225
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80647483</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1310608426</sourcerecordid><originalsourceid>FETCH-LOGICAL-a383t-ced8229e7dd841b067b0a2c96c53267da11f8078bc5b4a677e8a6907412c693c3</originalsourceid><addsrcrecordid>eNptkMtLxDAQh4Mo67p69SYUFEGkNY82SY-y-IIFLwrewjRNMUtfJu1h_evNsmUR8TQM883Mjw-hc4ITQgS_g3WfkBQneUIozQ7QnGQsiwWl8hDNMcY0zjP2cYxOvF-HFjNBZ2jGMyEkpnN0swRXQAPfpretiWwbDZ8mGpyBoTHtEHVVVIy1bSycoqMKam_OprpA748Pb8vnePX69LK8X8XAJBtibUpJaW5EWcqUFJiLAgPVOdcZo1yUQEglsZCFzooUuBBGAs-xSAnVPGeaLdD17m7vuq_R-EE11mtT19CabvRKYp6KVLIAXv4B193o2pBNEUYwxzKlPFDJjtKu896ZSvXONuA2imC1NaiCQRUMqlxtDYaFi-nsWDSm3OOTsjC_mubgNdSVg1Zbv8eCbUqEDNjtDoO-t7-S_f_0ByeYg_c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1310608426</pqid></control><display><type>article</type><title>Carbamazepine in the treatment of bulimia</title><source>MEDLINE</source><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><source>Periodicals Index Online</source><creator>KAPLAN, A. S ; GARFINKEL, P. E ; DARBY, P. L ; GARNER, D. M</creator><creatorcontrib>KAPLAN, A. S ; GARFINKEL, P. E ; DARBY, P. L ; GARNER, D. M</creatorcontrib><description>Of six bulimic outpatients who completed a double-blind crossover trial with carbamazepine, one patient, who had a history suggestive of bipolar disorder, responded dramatically with cessation of binge eating. This supports a possible link in some patients between bulimia and affective illness.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/ajp.140.9.1225</identifier><identifier>PMID: 6577802</identifier><identifier>CODEN: AJPSAO</identifier><language>eng</language><publisher>Washington, DC: American Psychiatric Publishing</publisher><subject>Adult ; Ambulatory Care ; Biological and medical sciences ; Bipolar Disorder - drug therapy ; Bipolar Disorder - physiopathology ; Carbamazepine - therapeutic use ; Double-Blind Method ; Feeding and Eating Disorders - drug therapy ; Female ; General and cellular metabolism. Vitamins ; Humans ; Hyperphagia - drug therapy ; Hyperphagia - physiopathology ; Limbic System - physiopathology ; Male ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>The American journal of psychiatry, 1983-09, Vol.140 (9), p.1225-1226</ispartof><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a383t-ced8229e7dd841b067b0a2c96c53267da11f8078bc5b4a677e8a6907412c693c3</citedby><cites>FETCH-LOGICAL-a383t-ced8229e7dd841b067b0a2c96c53267da11f8078bc5b4a677e8a6907412c693c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/ajp.140.9.1225$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/ajp.140.9.1225$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,780,784,2859,21629,27869,27924,27925,77791,77792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9532178$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6577802$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAPLAN, A. S</creatorcontrib><creatorcontrib>GARFINKEL, P. E</creatorcontrib><creatorcontrib>DARBY, P. L</creatorcontrib><creatorcontrib>GARNER, D. M</creatorcontrib><title>Carbamazepine in the treatment of bulimia</title><title>The American journal of psychiatry</title><addtitle>Am J Psychiatry</addtitle><description>Of six bulimic outpatients who completed a double-blind crossover trial with carbamazepine, one patient, who had a history suggestive of bipolar disorder, responded dramatically with cessation of binge eating. This supports a possible link in some patients between bulimia and affective illness.</description><subject>Adult</subject><subject>Ambulatory Care</subject><subject>Biological and medical sciences</subject><subject>Bipolar Disorder - drug therapy</subject><subject>Bipolar Disorder - physiopathology</subject><subject>Carbamazepine - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Feeding and Eating Disorders - drug therapy</subject><subject>Female</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Humans</subject><subject>Hyperphagia - drug therapy</subject><subject>Hyperphagia - physiopathology</subject><subject>Limbic System - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><recordid>eNptkMtLxDAQh4Mo67p69SYUFEGkNY82SY-y-IIFLwrewjRNMUtfJu1h_evNsmUR8TQM883Mjw-hc4ITQgS_g3WfkBQneUIozQ7QnGQsiwWl8hDNMcY0zjP2cYxOvF-HFjNBZ2jGMyEkpnN0swRXQAPfpretiWwbDZ8mGpyBoTHtEHVVVIy1bSycoqMKam_OprpA748Pb8vnePX69LK8X8XAJBtibUpJaW5EWcqUFJiLAgPVOdcZo1yUQEglsZCFzooUuBBGAs-xSAnVPGeaLdD17m7vuq_R-EE11mtT19CabvRKYp6KVLIAXv4B193o2pBNEUYwxzKlPFDJjtKu896ZSvXONuA2imC1NaiCQRUMqlxtDYaFi-nsWDSm3OOTsjC_mubgNdSVg1Zbv8eCbUqEDNjtDoO-t7-S_f_0ByeYg_c</recordid><startdate>198309</startdate><enddate>198309</enddate><creator>KAPLAN, A. S</creator><creator>GARFINKEL, P. E</creator><creator>DARBY, P. L</creator><creator>GARNER, D. M</creator><general>American Psychiatric Publishing</general><general>American Psychiatric Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HAWNG</scope><scope>HBMBR</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>7X8</scope></search><sort><creationdate>198309</creationdate><title>Carbamazepine in the treatment of bulimia</title><author>KAPLAN, A. S ; GARFINKEL, P. E ; DARBY, P. L ; GARNER, D. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a383t-ced8229e7dd841b067b0a2c96c53267da11f8078bc5b4a677e8a6907412c693c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adult</topic><topic>Ambulatory Care</topic><topic>Biological and medical sciences</topic><topic>Bipolar Disorder - drug therapy</topic><topic>Bipolar Disorder - physiopathology</topic><topic>Carbamazepine - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Feeding and Eating Disorders - drug therapy</topic><topic>Female</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Humans</topic><topic>Hyperphagia - drug therapy</topic><topic>Hyperphagia - physiopathology</topic><topic>Limbic System - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAPLAN, A. S</creatorcontrib><creatorcontrib>GARFINKEL, P. E</creatorcontrib><creatorcontrib>DARBY, P. L</creatorcontrib><creatorcontrib>GARNER, D. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 13</collection><collection>Periodicals Index Online Segment 14</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access &amp; Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access &amp; Build (Plan A) - APAC</collection><collection>Primary Sources Access &amp; Build (Plan A) - Canada</collection><collection>Primary Sources Access &amp; Build (Plan A) - West</collection><collection>Primary Sources Access &amp; Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - Midwest</collection><collection>Primary Sources Access &amp; Build (Plan A) - North Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Northeast</collection><collection>Primary Sources Access &amp; Build (Plan A) - South Central</collection><collection>Primary Sources Access &amp; Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAPLAN, A. S</au><au>GARFINKEL, P. E</au><au>DARBY, P. L</au><au>GARNER, D. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbamazepine in the treatment of bulimia</atitle><jtitle>The American journal of psychiatry</jtitle><addtitle>Am J Psychiatry</addtitle><date>1983-09</date><risdate>1983</risdate><volume>140</volume><issue>9</issue><spage>1225</spage><epage>1226</epage><pages>1225-1226</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><coden>AJPSAO</coden><abstract>Of six bulimic outpatients who completed a double-blind crossover trial with carbamazepine, one patient, who had a history suggestive of bipolar disorder, responded dramatically with cessation of binge eating. This supports a possible link in some patients between bulimia and affective illness.</abstract><cop>Washington, DC</cop><pub>American Psychiatric Publishing</pub><pmid>6577802</pmid><doi>10.1176/ajp.140.9.1225</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-953X
ispartof The American journal of psychiatry, 1983-09, Vol.140 (9), p.1225-1226
issn 0002-953X
1535-7228
language eng
recordid cdi_proquest_miscellaneous_80647483
source MEDLINE; Psychiatry Legacy Collection Online Journals 1844-1996; Periodicals Index Online
subjects Adult
Ambulatory Care
Biological and medical sciences
Bipolar Disorder - drug therapy
Bipolar Disorder - physiopathology
Carbamazepine - therapeutic use
Double-Blind Method
Feeding and Eating Disorders - drug therapy
Female
General and cellular metabolism. Vitamins
Humans
Hyperphagia - drug therapy
Hyperphagia - physiopathology
Limbic System - physiopathology
Male
Medical sciences
Pharmacology. Drug treatments
title Carbamazepine in the treatment of bulimia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T20%3A43%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbamazepine%20in%20the%20treatment%20of%20bulimia&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=KAPLAN,%20A.%20S&rft.date=1983-09&rft.volume=140&rft.issue=9&rft.spage=1225&rft.epage=1226&rft.pages=1225-1226&rft.issn=0002-953X&rft.eissn=1535-7228&rft.coden=AJPSAO&rft_id=info:doi/10.1176/ajp.140.9.1225&rft_dat=%3Cproquest_cross%3E1310608426%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1310608426&rft_id=info:pmid/6577802&rfr_iscdi=true